CD8A and glioblastoma: The high abundance of TAMs in GBM synchronously upregulates PD-L1 and Galectin-9 while collaborating with Tregs and MDSCs to suppress CD8+ T cell function, severely limiting the clinical efficacy of PD-1/PD-L1 blockade [18].